CONDENSED CONSOLIDATED STATEMENTS OF EQUITY - USD ($) shares in Thousands, $ in Thousands	Total	Common Stock	Additional Paid-In Capital	Accumulated Deficit
Equity at beginning of the period (in shares) at Dec. 31, 2022		269,094
Equity at beginning of the period at Dec. 31, 2022	$ 286,922	$ 269	$ 503,662	$ (217,008)
Increase (Decrease) in Stockholders' Equity [Roll Forward]
Net loss	(25,772)			(25,772)
Share-based compensation	868		868
Warrant expenses	480		480
Equity at end of the period (in shares) at Mar. 31, 2023		269,094
Equity at end of the period at Mar. 31, 2023	262,498	$ 269	505,009	(242,780)
Equity at beginning of the period (in shares) at Dec. 31, 2022		269,094
Equity at beginning of the period at Dec. 31, 2022	286,922	$ 269	503,662	(217,008)
Increase (Decrease) in Stockholders' Equity [Roll Forward]
Net loss	$ (88,392)
Equity at end of the period (in shares) at Sep. 30, 2023	269,209
Equity at end of the period at Sep. 30, 2023	$ 202,045	$ 269	507,176	(305,400)
Equity at beginning of the period (in shares) at Mar. 31, 2023		269,094
Equity at beginning of the period at Mar. 31, 2023	262,498	$ 269	505,009	(242,780)
Increase (Decrease) in Stockholders' Equity [Roll Forward]
Net loss	(31,410)			(31,410)
Share-based compensation and issuance of stock	650	$ 0	650
Share-based compensation and issuance of stock (in shares)		70
Equity at end of the period (in shares) at Jun. 30, 2023		269,164
Equity at end of the period at Jun. 30, 2023	231,738	$ 269	505,659	(274,190)
Increase (Decrease) in Stockholders' Equity [Roll Forward]
Net loss	(31,210)			(31,210)
Warrants exercised for common stock	$ 1		1
Warrants exercised for common stock (in shares)	0
Share-based compensation and issuance of stock	$ 1,515	$ 0	1,515
Share-based compensation and issuance of stock (in shares)		45
Equity at end of the period (in shares) at Sep. 30, 2023	269,209
Equity at end of the period at Sep. 30, 2023	$ 202,045	$ 269	507,176	(305,400)
Equity at beginning of the period (in shares) at Dec. 31, 2023		269,359
Equity at beginning of the period at Dec. 31, 2023	165,051	$ 269	509,448	(344,667)
Increase (Decrease) in Stockholders' Equity [Roll Forward]
Net loss	(25,296)			(25,296)
Share-based compensation and issuance for vested awards	1,126	$ 0	1,126
Share-based compensation and issuance for vested awards (in shares)		7
Equity at end of the period (in shares) at Mar. 31, 2024		269,366
Equity at end of the period at Mar. 31, 2024	140,881	$ 269	510,574	(369,963)
Equity at beginning of the period (in shares) at Dec. 31, 2023		269,359
Equity at beginning of the period at Dec. 31, 2023	165,051	$ 269	509,448	(344,667)
Increase (Decrease) in Stockholders' Equity [Roll Forward]
Net loss	$ (97,472)
Equity at end of the period (in shares) at Sep. 30, 2024	297,644
Equity at end of the period at Sep. 30, 2024	$ 163,665	$ 298	605,505	(442,138)
Equity at beginning of the period (in shares) at Mar. 31, 2024		269,366
Equity at beginning of the period at Mar. 31, 2024	140,881	$ 269	510,574	(369,963)
Increase (Decrease) in Stockholders' Equity [Roll Forward]
Net loss	(36,388)			(36,388)
Share-based compensation and issuance for vested awards	600	$ 0	600
Share-based compensation and issuance for vested awards (in shares)		160
Equity at end of the period (in shares) at Jun. 30, 2024		269,526
Equity at end of the period at Jun. 30, 2024	105,093	$ 270	511,174	(406,351)
Increase (Decrease) in Stockholders' Equity [Roll Forward]
Net loss	(35,787)			(35,787)
Issuance of common stock, net	85,187	$ 24	85,163
Issuance of common stock, net (in shares)		23,900
Warrants exchanged for common stock	8,120	$ 3	8,116
Warrants exchanged for common stock (in shares)		3,319
Warrants exercised for common stock	9	$ 1	8
Warrants exercised for common stock (in shares)		900
Share-based compensation	$ 1,044		1,044
Equity at end of the period (in shares) at Sep. 30, 2024	297,644
Equity at end of the period at Sep. 30, 2024	$ 163,665	$ 298	$ 605,505	$ (442,138)